Carolina Samper
Carolina Samper has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Juan Sebastián Frías-Ordoñez
Universidad Nacional de Colombia
3 shared publications - Viviana Parra Izquierdo
Hospital Internacional de Colombia, Santander, Colombia; Cellular and Molecular Immunology Group (INMUBO), Universidad El Bosque, Bogota, Colombia
3 shared publications - Fabian Eduardo Puentes Manosalva
Universidad de Caldas
2 shared publications - Fernando Sarmiento Quintero
Hospital of La Misericordia. Bogota. Colombia
2 shared publications - Melquicedec Vargas Sandoval
Universidad El Bosque
2 shared publications - Beatriz Iade Vergara
Asociación Crohn Colitis Ulcerosa Uruguay (ACCU) Department of Gastroenterology Montevideo
1 shared publication
Latest Publications
- Open Access
- 6 July 2026
- Published by Oxford University Press (OUP) in Crohn's & Colitis 360
- Vol. 8 (3) , otag055
The PANACEA Project: A Multinational Model for Digital Health Literacy in Inflammatory Bowel Disease
Background: Inflammatory bowel disease (IBD) represents an increasing public health challenge in Latin America, where structural inequities and limited access to standardized education contribute to gaps in health literacy. Despite the recognized role of patient education in IBD care, region-wide, structured digital initiatives remain limited. Objective: To describe the implementation, reach, and educational performance of PANACEA (PANamerican Crohn’s and Colitis Educational Approach), a multinational digital education program for patients with IBD and caregivers in Latin America. Methods: We conducted a multicenter observational descriptive study evaluating four consecutive PANACEA cohorts delivered between 2024 and 2025 through an asynchronous e-learning platform. Adults with IBD or caregivers voluntarily enrolled and completed standardized pre- and post-module knowledge assessments and satisfaction surveys. Program adherence, baseline characteristics, knowledge change, normalized learning gain, and user satisfaction were analyzed using descriptive statistics. Results: A total of 1,366 participants from 15 Latin American countries completed baseline assessments (mean age 41.4 years; 80% female). Sustained adherence to the platform was 53.1%. Cohorts with intermediate baseline knowledge demonstrated improvements in program-specific knowledge assessments (absolute improvement 8–9 points; normalized gain 0.43–0.52), while cohorts with high baseline scores exhibited ceiling effects. Participants with lower baseline knowledge tended to demonstrate greater relative improvements in knowledge scores. Satisfaction exceeded 90% across content quality, usability, and perceived usefulness. Conclusions: This observational evaluation demonstrates that PANACEA is a feasible and scalable digital education model for IBD in Latin America, achieving broad regional reach, high user satisfaction, and improvements in program-specific knowledge scores, particularly among participants with lower baseline knowledge levels.
- 6 July 2026
- Published by Oxford University Press (OUP) in Crohn's & Colitis 360
- Vol. 8 (3) , otag055
Open AccessThe PANACEA Project: A Multinational Model for Digital Health Literacy in Inflammatory Bowel Disease
Background: Inflammatory bowel disease (IBD) represents an increasing public health challenge in Latin America, where structural inequities and limited access to standardized education contribute to gaps in health literacy. Despite the recognized role of patient education in IBD care, region-wide, structured digital initiatives remain limited. Objective: To describe the implementation, reach, and educational performance of PANACEA (PANamerican Crohn’s and Colitis Educational Approach), a multinational digital education program for patients with IBD and caregivers in Latin America. Methods: We conducted a multicenter observational descriptive study evaluating four consecutive PANACEA cohorts delivered between 2024 and 2025 through an asynchronous e-learning platform. Adults with IBD or caregivers voluntarily enrolled and completed standardized pre- and post-module knowledge assessments and satisfaction surveys. Program adherence, baseline characteristics, knowledge change, normalized learning gain, and user satisfaction were analyzed using descriptive statistics. Results: A total of 1,366 participants from 15 Latin American countries completed baseline assessments (mean age 41.4 years; 80% female). Sustained adherence to the platform was 53.1%. Cohorts with intermediate baseline knowledge demonstrated improvements in program-specific knowledge assessments (absolute improvement 8–9 points; normalized gain 0.43–0.52), while cohorts with high baseline scores exhibited ceiling effects. Participants with lower baseline knowledge tended to demonstrate greater relative improvements in knowledge scores. Satisfaction exceeded 90% across content quality, usability, and perceived usefulness. Conclusions: This observational evaluation demonstrates that PANACEA is a feasible and scalable digital education model for IBD in Latin America, achieving broad regional reach, high user satisfaction, and improvements in program-specific knowledge scores, particularly among participants with lower baseline knowledge levels.
- Open Access
- 30 June 2025
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 45 (2) , 131-138
Perceived quality of life using IMPACT-III in a sample of Colombian children with IBD in remission: a cross-sectional study
Introduction: No data on quality of life (QoL) in paediatric IBD in Colombia. The aim of this study was to determine QoL using the IMPACT-III questionnaire in a sample of patients from different centres. Materials and methods: Cross-sectional study of paediatric IBD patients followed in 3 centres in different cities, between June and November 2022. Eligible subjects were identified, information was collected on different dates, and the IMPACT-III questionnaire (score ranges from 35 to 175, with higher scores indicating better QoL) was administered once. Results: 33 patients were included. 23/33 (69.7%) female, mean age 14.9 (range 6-17.9) years. 94% with inactive or mild disease. 20 patients with ulcerative colitis (UC), 13 with Crohn's disease (CD). The median score in UC was 147 (122-152), while in CD it was 126 (105-135). Systemic symptoms and emotional functioning were most affected, with median scores of 13 (12-14) and 27 (20-31) in UC and 11 (9-11) and 23 (20-26) in CD. No statistically significant differences were observed. Conclusions: The quality of life of children with IBD is challenging due to several factors. More support and education is needed for these patients.
- 30 June 2025
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 45 (2) , 131-138
Open AccessPerceived quality of life using IMPACT-III in a sample of Colombian children with IBD in remission: a cross-sectional study
Introduction: No data on quality of life (QoL) in paediatric IBD in Colombia. The aim of this study was to determine QoL using the IMPACT-III questionnaire in a sample of patients from different centres. Materials and methods: Cross-sectional study of paediatric IBD patients followed in 3 centres in different cities, between June and November 2022. Eligible subjects were identified, information was collected on different dates, and the IMPACT-III questionnaire (score ranges from 35 to 175, with higher scores indicating better QoL) was administered once. Results: 33 patients were included. 23/33 (69.7%) female, mean age 14.9 (range 6-17.9) years. 94% with inactive or mild disease. 20 patients with ulcerative colitis (UC), 13 with Crohn's disease (CD). The median score in UC was 147 (122-152), while in CD it was 126 (105-135). Systemic symptoms and emotional functioning were most affected, with median scores of 13 (12-14) and 27 (20-31) in UC and 11 (9-11) and 23 (20-26) in CD. No statistically significant differences were observed. Conclusions: The quality of life of children with IBD is challenging due to several factors. More support and education is needed for these patients.
- Open Access
- 12 April 2023
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 43 (2) , e1513
Calidad de vida relacionada con la salud por IBDQ-32 en pacientes colombianos con enfermedad inflamatoria intestinal en remisión: Un estudio de corte transversal
En Colombia no hay datos acerca de la percepción de la calidad de vida (CdV) en enfermedad inflamatoria intestinal (EII). Se plantea como objetivo determinar la percepción de la CdV mediante el cuestionario IBDQ-32 en pacientes con EII a partir de una muestra de pacientes de diferentes centros de referencia. Se realizó un estudio de corte transversal en adultos, con EII en remisión clínica, en seguimiento ambulatorio, en 3 instituciones en diferentes ciudades, entre junio 2022 a noviembre 2022, se identificaron sujetos elegibles, se recolectó información en fechas distintas, acerca aspectos sociodemográficos y clínicos, se evaluó el cuestionario IBDQ-32 en una ocasión y se realizó análisis descriptivo y analítico de las variables evaluadas. Como resultado, se obtuvieron 80 pacientes, 70% mujeres, edad media 38,5 (rango18-72; SD 13,25) años. 67,5% colitis ulcerosa (CU), 32,5% enfermedad de Crohn (EC). Se encontró compromiso moderado de la CdV (mediana 150 puntos, rango-intercuartílico 118,3-181,5) en EII, en CU mediana 151 (rango-intercuartílico 120-174,75) puntos, mientras en EC 133(rango-intercuartílico 106,25-186,25) puntos. Hubo mayor afección en dominio sistémico, con medianas 21 (rango-intercuartílico 15,8-27) puntos, y 18,5 (rango-intercuartílico 12,8-25,3) puntos, para CU y EC, respectivamente. Y, los menos afectados correspondieron al dominio digestivo y función social, en CU medianas 48,5 (rango-intercuartílico 40-58,3), y 27 (rango-intercuartílico 20,8-33); en EC medianas 43 (rango-intercuartílico 35,5-61,75) y 24,5 (rango-intercuartílico 18-32,5), respectivamente. No se encontraron diferencias estadísticamente significativas. Este estudio aporta información única acerca C bia. Se requiere seguir reforzando el acompañamiento, apoyo, y educación a los pacientes con EII.
- 12 April 2023
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 43 (2) , e1513
Open AccessCalidad de vida relacionada con la salud por IBDQ-32 en pacientes colombianos con enfermedad inflamatoria intestinal en remisión: Un estudio de corte transversal
En Colombia no hay datos acerca de la percepción de la calidad de vida (CdV) en enfermedad inflamatoria intestinal (EII). Se plantea como objetivo determinar la percepción de la CdV mediante el cuestionario IBDQ-32 en pacientes con EII a partir de una muestra de pacientes de diferentes centros de referencia. Se realizó un estudio de corte transversal en adultos, con EII en remisión clínica, en seguimiento ambulatorio, en 3 instituciones en diferentes ciudades, entre junio 2022 a noviembre 2022, se identificaron sujetos elegibles, se recolectó información en fechas distintas, acerca aspectos sociodemográficos y clínicos, se evaluó el cuestionario IBDQ-32 en una ocasión y se realizó análisis descriptivo y analítico de las variables evaluadas. Como resultado, se obtuvieron 80 pacientes, 70% mujeres, edad media 38,5 (rango18-72; SD 13,25) años. 67,5% colitis ulcerosa (CU), 32,5% enfermedad de Crohn (EC). Se encontró compromiso moderado de la CdV (mediana 150 puntos, rango-intercuartílico 118,3-181,5) en EII, en CU mediana 151 (rango-intercuartílico 120-174,75) puntos, mientras en EC 133(rango-intercuartílico 106,25-186,25) puntos. Hubo mayor afección en dominio sistémico, con medianas 21 (rango-intercuartílico 15,8-27) puntos, y 18,5 (rango-intercuartílico 12,8-25,3) puntos, para CU y EC, respectivamente. Y, los menos afectados correspondieron al dominio digestivo y función social, en CU medianas 48,5 (rango-intercuartílico 40-58,3), y 27 (rango-intercuartílico 20,8-33); en EC medianas 43 (rango-intercuartílico 35,5-61,75) y 24,5 (rango-intercuartílico 18-32,5), respectivamente. No se encontraron diferencias estadísticamente significativas. Este estudio aporta información única acerca C bia. Se requiere seguir reforzando el acompañamiento, apoyo, y educación a los pacientes con EII.